Metagenomi Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Metagenomi Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- MGX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001785279
Board of directors
-
Brian C. Thomas · Director · Chief Executive OfficerSince 2024
-
Eric Bjerkholt · DirectorSince 2025
-
Jian Irish · Director · Chief Executive OfficerSince 2024
-
Juergen Eckhardt · DirectorSince 2024
-
Laurence Reid · DirectorSince 2025
-
Sebastian Bernales · DirectorSince 2024
-
Willard H. Dere · DirectorSince 2024
Chief executives
Jian Irish
· Chief Executive Officer
Dates unknown
Brian C. Thomas
· Chief Executive Officer
Since February 2024
Board connections
2 of this board's directors also sit on 5 other boards.
- via Willard H. Dere
- via Eric Bjerkholt
- via Eric Bjerkholt
- via Willard H. Dere
- via Eric Bjerkholt
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $12,756
- 4 sales by 4 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 5, 2025 | Brian C. Thomas Director | Open-market sale | −3,830 | $1.77 | $6,779 |
| Dec 5, 2025 | Wein Matthew Officer (See Remarks) | Open-market sale | −199 | $1.77 | $352 |
| Dec 5, 2025 | Wapnick Pamela Officer (Chief Financial Officer) | Open-market sale | −1,576 | $1.77 | $2,790 |
| Dec 5, 2025 | Jian Irish Director, Officer (Chief Executive Officer) | Open-market sale | −1,602 | $1.77 | $2,836 |
| Dec 1, 2025 | Wapnick Pamela Officer (Chief Financial Officer) | Grant or award | +120,000 | $1.60 | $192,000 |
| Dec 1, 2025 | Jian Irish Director, Officer (Chief Executive Officer) | Grant or award | +37,500 | $1.60 | $60,000 |
| Dec 1, 2025 | Wein Matthew Officer (See Remarks) | Grant or award | +96,000 | $1.60 | $153,600 |
| Dec 1, 2025 | Jian Irish Director, Officer (Chief Executive Officer) | Grant or award | +211,000 | $1.60 | $337,600 |
| Sep 5, 2025 | Brian C. Thomas Director | Open-market sale | −2,701 | $1.81 | $4,889 |
| Sep 5, 2025 | Wapnick Pamela Officer (Chief Financial Officer) | Open-market sale | −1,576 | $1.81 | $2,853 |
| Sep 5, 2025 | Jian Irish Director, Officer (Chief Executive Officer) | Open-market sale | −1,602 | $1.81 | $2,900 |
| Sep 5, 2025 | Wein Matthew Officer (See Remarks) | Open-market sale | −199 | $1.81 | $360 |
| Jun 6, 2025 | Wein Matthew Officer (See Remarks) | Open-market sale | −199 | $1.75 | $348 |
| Jun 6, 2025 | Sarah B. Noonberg Officer (Chief Medical Officer) | Open-market sale | −5,239 | $1.75 | $9,168 |
| Jun 6, 2025 | Wapnick Pamela Officer (Chief Financial Officer) | Open-market sale | −1,576 | $1.75 | $2,758 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.